Abstract
Worldwide more than 350,000 patients will be diagnosed with oral cancer this year; however, the survival of patients with oral cancer has not changed significantly over the last 30 years. Recent reports have demonstrated that epithelial-mesenchymal transition (EMT) not only contributes to cancer cell invasion and metastasis but it is also associated with treatment resistance. In this review, we will examine the data demonstrating the role of EMT in oral cancer and the extent to which it contributes to poor response to current therapeutic modalities. We will also examine the interplay between EMT and microRNAs and review the role of microRNAs in modulating resistance of oral cancer cells to current therapeutic modalities. Similarly, we will review how EMT contributes to the generation and maintenance of stem cells and examine the role of stem cells in oral cancer recurrence and in modulating treatment resistance. Finally, we will examine how EMT is involved in fibrosis, which can limit delivery of therapeutic agents to cancer cells. Overall, this review will summarize our understanding of how EMT contributes to oral cancer progression and identify additional therapeutic targets that may help to reduce the morbidity and mortality associated with oral cancer.
Keywords: Epithelial-mesenchymal transition, microRNA, stem cells, fibrosis, oral cancer, treatment resistance, chemotherapy, E-cadherin, metalloproteinas, cytokine interleukin
Current Cancer Therapy Reviews
Title: Understanding Epithelial-Mesenchymal Transition may Reveal Novel Therapeutic Targets for Oral Squamous Cell Carcinoma
Volume: 7 Issue: 2
Author(s): Hidayatullah G. Munshi and M. Sharon Stack
Affiliation:
Keywords: Epithelial-mesenchymal transition, microRNA, stem cells, fibrosis, oral cancer, treatment resistance, chemotherapy, E-cadherin, metalloproteinas, cytokine interleukin
Abstract: Worldwide more than 350,000 patients will be diagnosed with oral cancer this year; however, the survival of patients with oral cancer has not changed significantly over the last 30 years. Recent reports have demonstrated that epithelial-mesenchymal transition (EMT) not only contributes to cancer cell invasion and metastasis but it is also associated with treatment resistance. In this review, we will examine the data demonstrating the role of EMT in oral cancer and the extent to which it contributes to poor response to current therapeutic modalities. We will also examine the interplay between EMT and microRNAs and review the role of microRNAs in modulating resistance of oral cancer cells to current therapeutic modalities. Similarly, we will review how EMT contributes to the generation and maintenance of stem cells and examine the role of stem cells in oral cancer recurrence and in modulating treatment resistance. Finally, we will examine how EMT is involved in fibrosis, which can limit delivery of therapeutic agents to cancer cells. Overall, this review will summarize our understanding of how EMT contributes to oral cancer progression and identify additional therapeutic targets that may help to reduce the morbidity and mortality associated with oral cancer.
Export Options
About this article
Cite this article as:
G. Munshi Hidayatullah and Stack M. Sharon, Understanding Epithelial-Mesenchymal Transition may Reveal Novel Therapeutic Targets for Oral Squamous Cell Carcinoma, Current Cancer Therapy Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/1573394711107020104
DOI https://dx.doi.org/10.2174/1573394711107020104 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links
Combinatorial Chemistry & High Throughput Screening Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Targeting of Drug Delivery Systems to Cancer
Current Drug Targets HR-MAS NMR Spectroscopy: A Practical Guide for Natural Samples
Current Organic Chemistry Ultra-deformable Liposomes as Flexible Nanovesicular Carrier to Penetrate Versatile Drugs Transdermally
Nanoscience & Nanotechnology-Asia Investigation of Human Papilloma Virus Associated with Oral Cancer with an Insight into Diagnostic Approaches and Recent Patents
Recent Patents on Biomarkers HPV Infections: Basis of Neoplastic Transformation and Related Molecular Tests
Current Pharmaceutical Design Methodological Issues of Clinical Research with EGFR Inhibitors
Current Cancer Therapy Reviews The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage
Current Cancer Drug Targets The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design Diffusion-Weighted Magnetic Resonance Imaging in Pelvic Cancer
Current Medical Imaging Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
Current Cancer Drug Targets Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry Targeted Drug Delivery Via Human Epidermal Growth Factor Receptor for Sustained Release of Allyl Isothiocyanate
Current Topics in Medicinal Chemistry The Association of Chemotherapy and Radiotherapy in Squamous Cell Carcinoma of Anal Canal
Current Drug Therapy Treatment of Elderly Patients Affected by Lung Cancer: Why to Treat, when to Treat and what we Know
Anti-Cancer Agents in Medicinal Chemistry Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma
Current Cancer Drug Targets Chemical Constituents and Biological Significance of the Genus Ilex (Aquifoliaceae)
The Natural Products Journal Periodontitis and Periodontal Disease - Innovative Strategies for Reversing the Chronic Infectious and Inflammatory Condition by Natural Products
Current Pharmaceutical Design Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Current Medicinal Chemistry